Positive effect on multiple sclerosis with treatment of metabolic syndrome

JAMA Neurology

Volumn 73, Issue 5, 2016, Pages 499-501

  Haghikia, Aiden ^a   Gold, Ralf ^a  

^a ST JOSEF HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; BETA1A INTERFERON; GADOLINIUM; INTERFERON BETA SERINE; LEPTIN; METFORMIN; OMEGA 3 FATTY ACID; ORAL ANTIDIABETIC AGENT; PIOGLITAZONE; PLACEBO; PROPIONIC ACID; RESISTIN;

AUTOIMMUNITY; BODY MASS; CELL DIFFERENTIATION; CELLULAR IMMUNITY; CONTRAST ENHANCEMENT; DIABETES MELLITUS; DIET; DISEASE ACTIVITY; EDITORIAL; ENVIRONMENTAL FACTOR; GENETIC VARIABILITY; HUMAN; LIFESTYLE; METABOLIC SYNDROME X; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; PLEIOTROPY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RISK FACTOR; SMOKING; VIRUS INFECTION; VITAMIN D DEFICIENCY;

HUMANS; METABOLIC SYNDROME; MULTIPLE SCLEROSIS;

EID: 84966691974     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2015.5050     Document Type: Editorial

References (12)

1. Negrotto L, Farez MF, Correale J. Immunologic effects of metformin and pioglitazone treatment on metabolic syndrome and multiple sclerosis [published online March 7, 2016]. JAMA Neurol. doi:10.1001/jamaneurol.2015.4807.
2. Ascherio A, Munger KL, Lünemann JD. The initiation and prevention of multiple sclerosis. Nat Rev Neurol. 2012;8(11):602-612.
3. Hedström AK, Sundqvist E, Bäärnhielm M, et al. Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis. Brain. 2011;134(pt 3):653-664.
4. Hedström AK, Lima Bomfim I, Barcellos L, et al. Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis. Neurology. 2014;82(10):865-872.
5. Sawcer S, Franklin RJ, Ban M. Multiple sclerosis genetics. Lancet Neurol. 2014;13(7):700-709.
6. Haghikia A, Hohlfeld R, Gold R, Fugger L. Therapies for multiple sclerosis: translational achievements and outstanding needs. Trends Mol Med. 2013;19(5):309-319.
7. Kleinewietfeld M, Manzel A, Titze J, et al. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature. 2013; 496(7446):518-522.
8. Torkildsen O, Wergeland S, Bakke S, et al. ω-3 fatty acid treatment in multiple sclerosis (OFAMS study): a randomized, double-blind, placebo-controlled trial. Arch Neurol. 2012;69(8): 1044-1051.
9. Haghikia A, Jörg S, Duscha A, et al. Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine. Immunity. 2015;43(4):817-829.
10. Berer K, Mues M, Koutrolos M, et al. Commensal microbiota andmyelin autoantigen cooperate to trigger autoimmune demyelination. Nature. 2011;479(7374):538-541.
11. Rosen ED, Spiegelman BM. Adipocytes as regulators of energy balance and glucose homeostasis. Nature. 2006;444(7121):847-853.
12. Moraes-Vieira PM, Larocca RA, Bassi EJ, et al. Leptin deficiency impairs maturation of dendritic cells and enhances induction of regulatory T and Th17 cells. Eur J Immunol. 2014;44(3):794-806.